FCA Corp TX Invests $186,000 in DENTSPLY SIRONA Inc (XRAY) Stock

FCA Corp TX acquired a new stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 4th quarter, HoldingsChannel reports. The fund acquired 5,000 shares of the medical instruments supplier’s stock, valued at approximately $186,000.

Other hedge funds have also recently made changes to their positions in the company. IFM Investors Pty Ltd lifted its stake in shares of DENTSPLY SIRONA by 1.8% in the 4th quarter. IFM Investors Pty Ltd now owns 13,533 shares of the medical instruments supplier’s stock worth $504,000 after purchasing an additional 245 shares during the period. Nomura Asset Management Co. Ltd. raised its stake in DENTSPLY SIRONA by 0.7% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 39,575 shares of the medical instruments supplier’s stock worth $1,473,000 after acquiring an additional 268 shares during the period. Private Capital Group LLC raised its stake in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 359 shares during the period. Diversified Trust Co raised its stake in DENTSPLY SIRONA by 10.8% during the 4th quarter. Diversified Trust Co now owns 6,867 shares of the medical instruments supplier’s stock worth $256,000 after acquiring an additional 672 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. 96.30% of the stock is currently owned by institutional investors.

A number of research firms have commented on XRAY. Barclays restated a “hold” rating and set a $39.00 target price on shares of DENTSPLY SIRONA in a research note on Sunday, January 6th. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Tuesday, December 25th. William Blair upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $56.71 target price on the stock in a research note on Monday, March 18th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Sunday, January 6th. Finally, UBS Group began coverage on shares of DENTSPLY SIRONA in a research note on Thursday, January 17th. They set a “neutral” rating and a $42.00 target price on the stock. One analyst has rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $52.12.

DENTSPLY SIRONA stock opened at $49.84 on Tuesday. The company has a market cap of $11.04 billion, a PE ratio of 24.77, a P/E/G ratio of 2.22 and a beta of 1.11. The company has a current ratio of 1.86, a quick ratio of 1.27 and a debt-to-equity ratio of 0.30. DENTSPLY SIRONA Inc has a 1 year low of $33.93 and a 1 year high of $51.13.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.04. The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.02 billion. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.82 earnings per share. As a group, analysts anticipate that DENTSPLY SIRONA Inc will post 2.31 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be given a dividend of $0.087 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Thursday, March 28th. DENTSPLY SIRONA’s payout ratio is currently 17.41%.

ILLEGAL ACTIVITY WARNING: This article was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://sportsperspectives.com/2019/04/02/fca-corp-tx-invests-186000-in-dentsply-sirona-inc-xray-stock.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: P/E Growth (PEG)

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.